1392 related articles for article (PubMed ID: 23916473)
41. High serum vascular endothelial growth factor levels predict poor prognosis after radiofrequency ablation of hepatocellular carcinoma: importance of tumor biomarker in ablative therapies.
Poon RT; Lau C; Pang R; Ng KK; Yuen J; Fan ST
Ann Surg Oncol; 2007 Jun; 14(6):1835-45. PubMed ID: 17406950
[TBL] [Abstract][Full Text] [Related]
42. Lymphocyte-to-monocyte ratio predicts survival of patients with hepatocellular carcinoma after curative resection.
Lin ZX; Ruan DY; Li Y; Wu DH; Ma XK; Chen J; Chen ZH; Li X; Wang TT; Lin Q; Wen JY; Wu XY
World J Gastroenterol; 2015 Oct; 21(38):10898-906. PubMed ID: 26478681
[TBL] [Abstract][Full Text] [Related]
43. Increased alpha-fetoprotein serum level is predictive for survival and recurrence of hepatocellular carcinoma in non-cirrhotic livers.
Witjes CD; Polak WG; Verhoef C; Eskens FA; Dwarkasing RS; Verheij J; de Man RA; Ijzermans JN
Dig Surg; 2012; 29(6):522-8. PubMed ID: 23548745
[TBL] [Abstract][Full Text] [Related]
44. Analysis of the risk factors of untransplantable recurrence after primary curative resection for patients with hepatocellular carcinoma.
Ho CM; Wu CY; Lee PH; Lai HS; Ho MC; Wu YM; Hu RH
Ann Surg Oncol; 2013 Aug; 20(8):2526-33. PubMed ID: 23504121
[TBL] [Abstract][Full Text] [Related]
45. A new prognostic model for hepatocellular carcinoma based on total tumor volume: the Taipei Integrated Scoring System.
Hsu CY; Huang YH; Hsia CY; Su CW; Lin HC; Loong CC; Chiou YY; Chiang JH; Lee PC; Huo TI; Lee SD
J Hepatol; 2010 Jul; 53(1):108-17. PubMed ID: 20451283
[TBL] [Abstract][Full Text] [Related]
46. Inter-alpha-trypsin inhibitor heavy chain H4 as a diagnostic and prognostic indicator in patients with hepatitis B virus-associated hepatocellular carcinoma.
Noh CK; Kim SS; Kim DK; Lee HY; Cho HJ; Yoon SY; Lee GH; Hyun SA; Kim YJ; Kim HJ; Hwang JA; Ahn SJ; Shin SJ; Lee KM; Yoo BM; Cho SW; Cheong JY
Clin Biochem; 2014 Sep; 47(13-14):1257-61. PubMed ID: 24836184
[TBL] [Abstract][Full Text] [Related]
47. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
[TBL] [Abstract][Full Text] [Related]
48. High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations.
Peng SY; Chen WJ; Lai PL; Jeng YM; Sheu JC; Hsu HC
Int J Cancer; 2004 Oct; 112(1):44-50. PubMed ID: 15305374
[TBL] [Abstract][Full Text] [Related]
49. Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein as a marker of prognosis and a monitor of recurrence of hepatocellular carcinoma after curative liver resection.
Zhang XF; Lai EC; Kang XY; Qian HH; Zhou YM; Shi LH; Shen F; Yang YF; Zhang Y; Lau WY; Wu MC; Yin ZF
Ann Surg Oncol; 2011 Aug; 18(8):2218-23. PubMed ID: 21336512
[TBL] [Abstract][Full Text] [Related]
50. High serum levels of vascular endothelial growth factor after hepatectomy are associated with poor prognosis in hepatocellular carcinoma.
Tamesa T; Iizuka N; Mori N; Okada T; Takemoto N; Tangoku A; Oka M
Hepatogastroenterology; 2009; 56(93):1122-6. PubMed ID: 19760954
[TBL] [Abstract][Full Text] [Related]
51. Serum alpha-fetoprotein response can predict prognosis in hepatocellular carcinoma patients undergoing radiofrequency ablation therapy.
Kao WY; Chiou YY; Hung HH; Su CW; Chou YH; Wu JC; Huo TI; Huang YH; Wu WC; Lin HC; Lee SD
Clin Radiol; 2012 May; 67(5):429-36. PubMed ID: 22153231
[TBL] [Abstract][Full Text] [Related]
52. Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma.
Liu X; Chi X; Gong Q; Gao L; Niu Y; Chi X; Cheng M; Si Y; Wang M; Zhong J; Niu J; Yang W
PLoS One; 2015; 10(5):e0127518. PubMed ID: 25996938
[TBL] [Abstract][Full Text] [Related]
53. Diagnostic and prognostic role of alpha-fetoprotein in hepatocellular carcinoma: both or neither?
Farinati F; Marino D; De Giorgio M; Baldan A; Cantarini M; Cursaro C; Rapaccini G; Del Poggio P; Di Nolfo MA; Benvegnù L; Zoli M; Borzio F; Bernardi M; Trevisani F
Am J Gastroenterol; 2006 Mar; 101(3):524-32. PubMed ID: 16542289
[TBL] [Abstract][Full Text] [Related]
54. AFP mRNA detected in bone marrow by real-time quantitative RT-PCR analysis predicts survival and recurrence after curative hepatectomy for hepatocellular carcinoma.
Kamiyama T; Takahashi M; Nakagawa T; Nakanishi K; Kamachi H; Suzuki T; Shimamura T; Taniguchi M; Ozaki M; Matsushita M; Furukawa H; Todo S
Ann Surg; 2006 Sep; 244(3):451-63. PubMed ID: 16926571
[TBL] [Abstract][Full Text] [Related]
55. Alpha-fetoprotein still is a valuable diagnostic and prognosis predicting biomarker in hepatitis B virus infection-related hepatocellular carcinoma.
Yao M; Zhao J; Lu F
Oncotarget; 2016 Jan; 7(4):3702-8. PubMed ID: 26784252
[TBL] [Abstract][Full Text] [Related]
56. Half-life of serum alpha-fetoprotein: an early prognostic index of recurrence and survival after hepatic resection for hepatocellular carcinoma.
Shim JH; Han S; Lee YJ; Lee SG; Kim KM; Lim YS; Chung YH; Lee YS; Lee HC
Ann Surg; 2013 Apr; 257(4):708-17. PubMed ID: 23108121
[TBL] [Abstract][Full Text] [Related]
57. SUOX is a promising diagnostic and prognostic biomarker for hepatocellular carcinoma.
Jin GZ; Yu WL; Dong H; Zhou WP; Gu YJ; Yu H; Yu H; Lu XY; Xian ZH; Liu YK; Cong WM; Wu MC
J Hepatol; 2013 Sep; 59(3):510-7. PubMed ID: 23665285
[TBL] [Abstract][Full Text] [Related]
58. The significance of serum AFP cut-off values, 20 and 400 ng/mL in curatively resected patients with hepatocellular carcinoma and cirrhosis might be of difference.
Zhou L; Rui JA; Wang SB; Chen SG; Qu Q
Hepatogastroenterology; 2012 May; 59(115):840-3. PubMed ID: 22469729
[TBL] [Abstract][Full Text] [Related]
59. Alpha-fetoprotein: the predictor of microvascular invasion in solitary small hepatocellular carcinoma and criterion for anatomic or non-anatomic hepatic resection.
Fan LF; Zhao WC; Yang N; Yang GS
Hepatogastroenterology; 2013 Jun; 60(124):825-36. PubMed ID: 23321029
[TBL] [Abstract][Full Text] [Related]
60. Evaluation of prognostic factors on recurrence after curative resections for hepatocellular carcinoma.
Han JH; Kim DG; Na GH; Kim EY; Lee SH; Hong TH; You YK
World J Gastroenterol; 2014 Dec; 20(45):17132-40. PubMed ID: 25493027
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]